Leslie E. Lehmann, MD

Clinical Director, Pediatric Stem Cell Transplant Center
Institute Physician
Assistant Professor of Pediatrics, Harvard Medical School
Office Phone: 617-632-4882
Appointment Phone: 617-632-3961
Fax: 617-632-2095
Preferred Contact Method: email


Treatment Centers
Pediatric Hematology/Oncology
Clinical Interests
Hematopoietic stem cell transplantation, Late effects of transplantation, Second transplants, Role of exercise in stem cell transplantation, Stem cell transplantation for sickle cell disease and thalassemia, Transplants for bone marrow failure syndromes, Global health


Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA  02215


Board Certifications
Pediatric Hematology/Oncology
Pediatrics, 1992
Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology
Duke University, Pediatrics
Medical School
Duke University
Dr. Lehmann attended Harvard College and received her MD from Duke University Medical School, where, after finishing a pediatric residency, she spent a year as chief resident. She completed a pediatric hematology-oncology fellowship at DFCI/Children's Hospital Boston in 1996 and subsequently joined the faculty. In 1998, she became medical director of the Pediatric Transplant Unit at Children's Hospital and, in 2007, was appointed clinical director of the Pediatric Stem Cell Transplant Program.

Video: Meet Leslie E. Lehmann

Lesley Lehmann, MD, describes the unique pediatric stem cell transplant care available at Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

Appointments & Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Clinical Trials

Search our wide range of clinical trials, including novel therapies, immunotherapy and personalized therapy.callout bg

Harvard Medical Affiliate

HMS Callout FAD 

As a teaching affiliate of Harvard Medical School, our physicians are passing on their expertise to the next generation of pediatric hematologists and oncologists.